Oncology

Nearly 10 million cancer screenings were delayed in the U.S. from January to July 2020 as a result of the COVID-19 pandemic, an American Association of Cancer Research report published Feb. 9 found.

Here are four announcements from the American Cancer Society reported by Becker's since Jan. 14:

Here are five oncology-related partnerships Becker's has covered since Jan. 25: 

Current tests for HER2 breast cancer may cause misassignment in treatment types, driving a need to create a new test, a Yale Cancer Center study published Feb. 3 in JAMA Oncology found.

Hundreds of millions of dollars have been donated to fund specialty cancer centers and accelerate cancer research in recent weeks. 

The American Cancer Society and Sleep Number Corp. have agreed to work together on sleep research to inform the first sleep guidelines for cancer patients, the organizations said Feb. 2. 

Two early recipients of CAR T-cell therapy — who had chronic lymphocytic leukemia at the time of treatment — remain cancer-free a decade later, researchers from the University of Pennsylvania in Philadelphia reported Feb. 2. 

About 39 percent of oncologists reported they have been named in a malpractice suit at some point in their career, according to Medscape's 2021 Oncology Malpractice Report published Jan. 31. 

Tampa, Fla.-based Moffitt Cancer Center is the newest member of Employer Direct Healthcare in Dallas, a company offering self-funded employers turnkey solutions for specialty care.

News of the clinical affiliation of Edison, N.J.-based Hackensack Meridian Health and Paterson, N.J.-based St. Joseph's Health was Becker's most read oncology story in January.